Docetaxel and Peripheral sensorimotor neuropathy - a phase IV clinical study of FDA data

Summary:

Peripheral sensorimotor neuropathy is reported as a side effect among people who take Docetaxel (docetaxel), especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months also take Carboplatin, and have Breast cancer.

The phase IV clinical study analyzes which people have Peripheral sensorimotor neuropathy when taking Docetaxel. It is created by eHealthMe based on reports of 79,811 people who have side effects when taking Docetaxel from the FDA, and is updated regularly.

What is Docetaxel?

Docetaxel has active ingredients of docetaxel. eHealthMe is studying from 79,875 Docetaxel users. Check the latest studies of Docetaxel.

What is Peripheral sensorimotor neuropathy?

Peripheral sensorimotor neuropathy (damage to one or more of your peripheral nerves) is found to be associated with 185 drugs and 323 conditions by eHealthMe. Check the latest studies of Peripheral sensorimotor neuropathy.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 22, 2026

79,811 people reported to have side effects when taking Docetaxel.
Among them, 14 people (0.02%) have Peripheral sensorimotor neuropathy.

Could Docetaxel cause Peripheral sensorimotor neuropathy?

Among these 14 people:

How long have people been on Docetaxel when they have Peripheral sensorimotor neuropathy? *

What is the gender of people who have Peripheral sensorimotor neuropathy when taking Docetaxel? *

female: 75 %
male: 25 %

What is the age of people who have Peripheral sensorimotor neuropathy when taking Docetaxel? *

What are other drugs people take besides Docetaxel? *

What are other side effects people have besides Peripheral sensorimotor neuropathy? *

Bone Pain: 3 people, 21.43%
Diarrhea: 3 people, 21.43%
Weakness: 2 people, 14.29%
Rashes (redness): 2 people, 14.29%
Muscle Aches (muscle pain): 2 people, 14.29%
Generalised Oedema (swelling all over the body): 2 people, 14.29%
Nosebleed (bleeding from nose): 2 people, 14.29%
Metastases To Central Nervous System (cancer spreads to central nervous system): 2 people, 14.29%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 2 people, 14.29%
Cytomegalovirus Test Positive: 1 person, 7.14%

What are the existing conditions these people have? *

Breast Cancer: 9 people, 64.29%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 7.14%
Prostate Cancer Metastatic: 1 person, 7.14%
Prostate Cancer: 1 person, 7.14%
Metastatic Gastric Cancer (cancer types can spread to the stomach from other place): 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Docetaxel and have Peripheral sensorimotor neuropathy?

- Check whether Peripheral sensorimotor neuropathy is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Docetaxel:

Docetaxel (79,875 reports)

Browse all side effects of Docetaxel:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Peripheral sensorimotor neuropathy:

Peripheral sensorimotor neuropathy (185 drugs)

Browse all the conditions that are associated with Peripheral sensorimotor neuropathy:

Peripheral sensorimotor neuropathy (323 conditions)

Related publications that referenced our studies

Byun JS, Kang SH, Lee MJ, Kim SY, Choi HG, Lee HR, "A Case of Scleroderma-like Cutaneous Lesions Induced by Docetaxel in a Patient with Breast Cancer", Journal of Rheumatic Diseases, 2013 Oct .
Byun JS, Kang SH, Lee MJ, Kim SY, Choi HG, Lee HR, "A Case of Scleroderma-like Cutaneous Lesions Induced by Docetaxel in a Patient with Breast Cancer", Journal of Rheumatic Diseases, 2013 Oct .

How the study uses the data?

The study uses data from the FDA. It is based on docetaxel (the active ingredients of Docetaxel) and Docetaxel (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.